Lin Gan Selected Research

Yin Deficiency (Yinxu)

1/2020	Identification of potential metabolic biomarkers in Yin deficiency syndrome using LC-MS.
1/2020	A group of serum proteins as potential diagnostic biomarkers for Yin-deficiency-heat syndrome.
1/2020	Screening of potential biomarkers for Yin-deficiency-heat syndrome based on UHPLC-MS method and the mechanism of Zhibai Dihuang granule therapeutic effect.
1/2020	Study on potential biomarkers of energy metabolism-related to early-stage Yin-deficiency-heat syndrome based on metabolomics and transcriptomics.
10/2018	The Chinese herbal formula Zhibai Dihuang Granule treat Yin-deficiency-heat syndrome rats by regulating the immune responses.
1/2018	iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat syndrome rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lin Gan Research Topics

Disease

11	Infections 01/2022 - 04/2009
10	Neoplasms (Cancer) 11/2021 - 03/2004
7	Acute Intermittent Porphyria (Porphyria, Acute) 11/2019 - 01/2010
6	Inflammation (Inflammations) 08/2021 - 02/2010
6	Yin Deficiency (Yinxu) 01/2020 - 01/2018
6	Schizophrenia (Dementia Praecox) 01/2018 - 02/2013
5	Ganglion Cysts (Ganglion) 07/2019 - 01/2007
5	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 03/2009
4	Human Influenza (Influenza) 01/2022 - 12/2018
3	Hypertension (High Blood Pressure) 01/2022 - 01/2021
3	Carcinogenesis 11/2021 - 03/2004
3	Hepatic Porphyrias (Hepatic Porphyria) 11/2015 - 01/2010
3	Prostatic Neoplasms (Prostate Cancer) 02/2009 - 02/2008
3	Reperfusion Injury 03/2005 - 10/2003
2	Ischemic Stroke 01/2022 - 01/2021
2	Pneumonia (Pneumonitis) 01/2022 - 11/2021
2	Triple Negative Breast Neoplasms 01/2022 - 01/2020
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2021 - 09/2020
2	Fabry Disease (Fabry's Disease) 11/2021 - 09/2020
2	Pain (Aches) 01/2020 - 04/2016
2	Lung Neoplasms (Lung Cancer) 09/2019 - 05/2016
2	Pulmonary Tuberculosis 01/2018 - 12/2017
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 03/2015 - 01/2014
2	Glomerulonephritis 04/2013 - 10/2011
2	Herpes Zoster 03/2011 - 02/2010
2	Chickenpox 03/2011 - 02/2010
2	Fibrosis (Cirrhosis) 11/2010 - 04/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2010 - 04/2010
1	Colonic Neoplasms (Colon Cancer) 11/2022
1	Cerebral Infarction 04/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2022
1	Cerebral Hemorrhage 01/2022
1	Osteoporosis 01/2022
1	Brain Stem Infarctions (Weber Syndrome) 01/2022
1	Hyperaldosteronism (Conn Syndrome) 01/2022
1	Aortic Dissection 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Glucose Metabolism Disorders 01/2022
1	Stroke (Strokes) 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Deglutition Disorders (Dysphagia) 01/2022
1	False Aneurysm (Pseudoaneurysm) 01/2022
1	Proteinuria 01/2022
1	Liver Abscess 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 09/2019 - 02/2008
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2010
7	VaccinesIBA 12/2021 - 04/2009
4	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 11/2019 - 01/2010
4	Heme (Haem)IBA 01/2019 - 01/2010
4	Retinaldehyde (Retinal)IBA 03/2015 - 01/2007
4	Messenger RNA (mRNA)IBA 04/2013 - 02/2008
3	AldosteroneIBA 01/2022 - 01/2022
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
3	CytokinesIBA 08/2021 - 10/2015
3	LigandsIBA 06/2020 - 01/2011
3	zhibai dihuangIBA 01/2020 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 03/2004
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 07/2006
3	Small Interfering RNA (siRNA)IBA 11/2015 - 07/2005
3	Biological ProductsIBA 07/2015 - 08/2012
3	StathminIBA 01/2014 - 04/2010
3	NF-kappa B (NF-kB)IBA 02/2010 - 03/2005
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 12/2021
2	Colistin (Coly-Mycin)FDA Link 01/2022 - 11/2021
2	COVID-19 VaccinesIBA 12/2021 - 01/2021
2	globotriaosylceramide (globotriosylceramide)IBA 11/2021 - 09/2020
2	GalactosidasesIBA 11/2021 - 12/2018
2	EnzymesIBA 11/2021 - 09/2020
2	AntigensIBA 11/2021 - 04/2009
2	Lysine (L-Lysine)FDA Link 05/2021 - 10/2020
2	Therapeutic UsesIBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 07/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 12/2018
2	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 12/2018
2	AcidsIBA 01/2019 - 01/2018
2	P-2 (P 2)IBA 11/2015 - 05/2015
2	GTP Phosphohydrolases (GTPases)IBA 03/2015 - 01/2014
2	Telmisartan (Micardis)FDA Link 04/2013 - 10/2011
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2013 - 10/2011
2	AndrogensIBA 02/2009 - 02/2008
1	Evans Blue (Blue, Evans)FDA Link 04/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2022
1	ReninIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Dioctyl Sulfosuccinic Acid (DOSS)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Sulbactam FDA LinkGeneric 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	salmochelinIBA 01/2022

Therapy/Procedure

14	Therapeutics 01/2022 - 06/2005
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2018
2	Skin Transplantation (Skin Grafting) 01/2013 - 01/2011
1	Adjuvant Chemotherapy 11/2022
1	Dry Needling 01/2022
1	Thrombectomy 01/2022
1	Minimally Invasive Surgical Procedures 01/2022